Loading…

Predictors of poor clinical outcome of cryptococcal meningitis in HIV-infected patients

The aim of this study was to identify baseline prognostic factors for poor clinical outcome of HIV-associated cryptococcal meningitis. We conducted a trial in Thailand and the USA comparing low- and high-dose concomitant use of amphotericin B and fluconazole for HIV-associated cryptococcal meningiti...

Full description

Saved in:
Bibliographic Details
Published in:International journal of STD & AIDS 2011-11, Vol.22 (11), p.665-670
Main Authors: Anekthananon, T, Manosuthi, W, Chetchotisakd, P, Kiertiburanakul, S, Supparatpinyo, K, Ratanasuwan, W, Pappas, P G, Filler, S G, Kopetskie, H A, Nolen, T L, Kendrick, A S, Larsen, R A
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c398t-a93358962a190cc2fa1208c31b6ef700af7974742ca735c01a57a8f0049aecf73
cites cdi_FETCH-LOGICAL-c398t-a93358962a190cc2fa1208c31b6ef700af7974742ca735c01a57a8f0049aecf73
container_end_page 670
container_issue 11
container_start_page 665
container_title International journal of STD & AIDS
container_volume 22
creator Anekthananon, T
Manosuthi, W
Chetchotisakd, P
Kiertiburanakul, S
Supparatpinyo, K
Ratanasuwan, W
Pappas, P G
Filler, S G
Kopetskie, H A
Nolen, T L
Kendrick, A S
Larsen, R A
description The aim of this study was to identify baseline prognostic factors for poor clinical outcome of HIV-associated cryptococcal meningitis. We conducted a trial in Thailand and the USA comparing low- and high-dose concomitant use of amphotericin B and fluconazole for HIV-associated cryptococcal meningitis to amphotericin B followed by fluconazole. Subjects who were either alive and cerebrospinal fluid (CSF) culture-positive or dead were considered to have a poor outcome. At day 14, baseline characteristics associated with poor outcome included: low weight, high CSF cryptococcal antigen (CrAg) titre and low CSF white blood cell (WBC) count. At day 70, the associated baseline characteristics included: CSF CrAg titre >1:1024 and low Karnofsky performance status. Overall, consistent with published findings, low weight, high CSF CrAg titre and low CSF WBC counts at baseline were predictors for poor clinical outcome. In addition, we found that low Karnofsky performance status was predictive of poor outcome. Prompt management with appropriate antifungal therapy for this particular group of patients may improve the outcomes.
doi_str_mv 10.1258/ijsa.2011.010538
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_912917549</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1258_ijsa.2011.010538</sage_id><sourcerecordid>911162522</sourcerecordid><originalsourceid>FETCH-LOGICAL-c398t-a93358962a190cc2fa1208c31b6ef700af7974742ca735c01a57a8f0049aecf73</originalsourceid><addsrcrecordid>eNqNkD1rHDEQhkVwiC9O-lRmG-NqLyPtaiWVxtixwZAU-SiFPCcZHbvSWtIW_vfRcpe4CqQaZuZ5Z-Ah5BOFLWVcfvb7bLYMKN0CBd7JN2RDBZdtbdgJ2YDiQ9sPrD8l73PeA8DQCfWOnDIGaqiBDfn1LdmdxxJTbqJr5hhTg6MPHs3YxKVgnOy6wPQyl4gR1_lkgw9Pvvjc-NDc3f9sfXAWi901synehpI_kLfOjNl-PNYz8uP25vv1Xfvw9cv99dVDi52SpTWq67hUAzNUASJzhjKQ2NHHwToBYJxQohc9QyM6jkANF0Y6gF4Zi050Z-TycHdO8XmxuejJZ7TjaIKNS9aKMlWV9Oo_SEoHxhmrJBxITDHnZJ2ek59MetEU9Opdr9716l0fvNfI-fH48jjZ3d_AH9EVuDgCJleFLpmAPr9ynMmBSqhce-CyebJ6H5cUqr5_P_4N-8GZaA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>911162522</pqid></control><display><type>article</type><title>Predictors of poor clinical outcome of cryptococcal meningitis in HIV-infected patients</title><source>Sage Journals Online</source><creator>Anekthananon, T ; Manosuthi, W ; Chetchotisakd, P ; Kiertiburanakul, S ; Supparatpinyo, K ; Ratanasuwan, W ; Pappas, P G ; Filler, S G ; Kopetskie, H A ; Nolen, T L ; Kendrick, A S ; Larsen, R A</creator><creatorcontrib>Anekthananon, T ; Manosuthi, W ; Chetchotisakd, P ; Kiertiburanakul, S ; Supparatpinyo, K ; Ratanasuwan, W ; Pappas, P G ; Filler, S G ; Kopetskie, H A ; Nolen, T L ; Kendrick, A S ; Larsen, R A ; BAMSG 3-01 Study Team ; The Bamsg 3-01 Study Team</creatorcontrib><description>The aim of this study was to identify baseline prognostic factors for poor clinical outcome of HIV-associated cryptococcal meningitis. We conducted a trial in Thailand and the USA comparing low- and high-dose concomitant use of amphotericin B and fluconazole for HIV-associated cryptococcal meningitis to amphotericin B followed by fluconazole. Subjects who were either alive and cerebrospinal fluid (CSF) culture-positive or dead were considered to have a poor outcome. At day 14, baseline characteristics associated with poor outcome included: low weight, high CSF cryptococcal antigen (CrAg) titre and low CSF white blood cell (WBC) count. At day 70, the associated baseline characteristics included: CSF CrAg titre &gt;1:1024 and low Karnofsky performance status. Overall, consistent with published findings, low weight, high CSF CrAg titre and low CSF WBC counts at baseline were predictors for poor clinical outcome. In addition, we found that low Karnofsky performance status was predictive of poor outcome. Prompt management with appropriate antifungal therapy for this particular group of patients may improve the outcomes.</description><identifier>ISSN: 0956-4624</identifier><identifier>EISSN: 1758-1052</identifier><identifier>DOI: 10.1258/ijsa.2011.010538</identifier><identifier>PMID: 22096053</identifier><language>eng</language><publisher>London, England: SAGE Publications</publisher><subject>AIDS/HIV ; Amphotericin B - administration &amp; dosage ; Antifungal Agents - administration &amp; dosage ; Biological and medical sciences ; Cerebrospinal Fluid - microbiology ; Cryptococcus ; Fluconazole - administration &amp; dosage ; General aspects ; HIV Infections - complications ; Human immunodeficiency virus ; Human mycoses ; Human viral diseases ; Humans ; Infectious diseases ; Medical sciences ; Meningitis, Cryptococcal - diagnosis ; Meningitis, Cryptococcal - drug therapy ; Meningitis, Cryptococcal - mortality ; Meningitis, Cryptococcal - pathology ; Miscellaneous mycoses ; Mycoses ; Prognosis ; Survival Analysis ; Thailand ; Treatment Outcome ; United States ; Viral diseases ; Viral diseases of the lymphoid tissue and the blood. Aids</subject><ispartof>International journal of STD &amp; AIDS, 2011-11, Vol.22 (11), p.665-670</ispartof><rights>2011 SAGE Publications</rights><rights>2015 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c398t-a93358962a190cc2fa1208c31b6ef700af7974742ca735c01a57a8f0049aecf73</citedby><cites>FETCH-LOGICAL-c398t-a93358962a190cc2fa1208c31b6ef700af7974742ca735c01a57a8f0049aecf73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925,79364</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=25286180$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22096053$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Anekthananon, T</creatorcontrib><creatorcontrib>Manosuthi, W</creatorcontrib><creatorcontrib>Chetchotisakd, P</creatorcontrib><creatorcontrib>Kiertiburanakul, S</creatorcontrib><creatorcontrib>Supparatpinyo, K</creatorcontrib><creatorcontrib>Ratanasuwan, W</creatorcontrib><creatorcontrib>Pappas, P G</creatorcontrib><creatorcontrib>Filler, S G</creatorcontrib><creatorcontrib>Kopetskie, H A</creatorcontrib><creatorcontrib>Nolen, T L</creatorcontrib><creatorcontrib>Kendrick, A S</creatorcontrib><creatorcontrib>Larsen, R A</creatorcontrib><creatorcontrib>BAMSG 3-01 Study Team</creatorcontrib><creatorcontrib>The Bamsg 3-01 Study Team</creatorcontrib><title>Predictors of poor clinical outcome of cryptococcal meningitis in HIV-infected patients</title><title>International journal of STD &amp; AIDS</title><addtitle>Int J STD AIDS</addtitle><description>The aim of this study was to identify baseline prognostic factors for poor clinical outcome of HIV-associated cryptococcal meningitis. We conducted a trial in Thailand and the USA comparing low- and high-dose concomitant use of amphotericin B and fluconazole for HIV-associated cryptococcal meningitis to amphotericin B followed by fluconazole. Subjects who were either alive and cerebrospinal fluid (CSF) culture-positive or dead were considered to have a poor outcome. At day 14, baseline characteristics associated with poor outcome included: low weight, high CSF cryptococcal antigen (CrAg) titre and low CSF white blood cell (WBC) count. At day 70, the associated baseline characteristics included: CSF CrAg titre &gt;1:1024 and low Karnofsky performance status. Overall, consistent with published findings, low weight, high CSF CrAg titre and low CSF WBC counts at baseline were predictors for poor clinical outcome. In addition, we found that low Karnofsky performance status was predictive of poor outcome. Prompt management with appropriate antifungal therapy for this particular group of patients may improve the outcomes.</description><subject>AIDS/HIV</subject><subject>Amphotericin B - administration &amp; dosage</subject><subject>Antifungal Agents - administration &amp; dosage</subject><subject>Biological and medical sciences</subject><subject>Cerebrospinal Fluid - microbiology</subject><subject>Cryptococcus</subject><subject>Fluconazole - administration &amp; dosage</subject><subject>General aspects</subject><subject>HIV Infections - complications</subject><subject>Human immunodeficiency virus</subject><subject>Human mycoses</subject><subject>Human viral diseases</subject><subject>Humans</subject><subject>Infectious diseases</subject><subject>Medical sciences</subject><subject>Meningitis, Cryptococcal - diagnosis</subject><subject>Meningitis, Cryptococcal - drug therapy</subject><subject>Meningitis, Cryptococcal - mortality</subject><subject>Meningitis, Cryptococcal - pathology</subject><subject>Miscellaneous mycoses</subject><subject>Mycoses</subject><subject>Prognosis</subject><subject>Survival Analysis</subject><subject>Thailand</subject><subject>Treatment Outcome</subject><subject>United States</subject><subject>Viral diseases</subject><subject>Viral diseases of the lymphoid tissue and the blood. Aids</subject><issn>0956-4624</issn><issn>1758-1052</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><recordid>eNqNkD1rHDEQhkVwiC9O-lRmG-NqLyPtaiWVxtixwZAU-SiFPCcZHbvSWtIW_vfRcpe4CqQaZuZ5Z-Ah5BOFLWVcfvb7bLYMKN0CBd7JN2RDBZdtbdgJ2YDiQ9sPrD8l73PeA8DQCfWOnDIGaqiBDfn1LdmdxxJTbqJr5hhTg6MPHs3YxKVgnOy6wPQyl4gR1_lkgw9Pvvjc-NDc3f9sfXAWi901synehpI_kLfOjNl-PNYz8uP25vv1Xfvw9cv99dVDi52SpTWq67hUAzNUASJzhjKQ2NHHwToBYJxQohc9QyM6jkANF0Y6gF4Zi050Z-TycHdO8XmxuejJZ7TjaIKNS9aKMlWV9Oo_SEoHxhmrJBxITDHnZJ2ek59MetEU9Opdr9716l0fvNfI-fH48jjZ3d_AH9EVuDgCJleFLpmAPr9ynMmBSqhce-CyebJ6H5cUqr5_P_4N-8GZaA</recordid><startdate>20111101</startdate><enddate>20111101</enddate><creator>Anekthananon, T</creator><creator>Manosuthi, W</creator><creator>Chetchotisakd, P</creator><creator>Kiertiburanakul, S</creator><creator>Supparatpinyo, K</creator><creator>Ratanasuwan, W</creator><creator>Pappas, P G</creator><creator>Filler, S G</creator><creator>Kopetskie, H A</creator><creator>Nolen, T L</creator><creator>Kendrick, A S</creator><creator>Larsen, R A</creator><general>SAGE Publications</general><general>Royal Society of Medicine Press</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7U9</scope><scope>H94</scope><scope>M7N</scope><scope>7X8</scope></search><sort><creationdate>20111101</creationdate><title>Predictors of poor clinical outcome of cryptococcal meningitis in HIV-infected patients</title><author>Anekthananon, T ; Manosuthi, W ; Chetchotisakd, P ; Kiertiburanakul, S ; Supparatpinyo, K ; Ratanasuwan, W ; Pappas, P G ; Filler, S G ; Kopetskie, H A ; Nolen, T L ; Kendrick, A S ; Larsen, R A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c398t-a93358962a190cc2fa1208c31b6ef700af7974742ca735c01a57a8f0049aecf73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>AIDS/HIV</topic><topic>Amphotericin B - administration &amp; dosage</topic><topic>Antifungal Agents - administration &amp; dosage</topic><topic>Biological and medical sciences</topic><topic>Cerebrospinal Fluid - microbiology</topic><topic>Cryptococcus</topic><topic>Fluconazole - administration &amp; dosage</topic><topic>General aspects</topic><topic>HIV Infections - complications</topic><topic>Human immunodeficiency virus</topic><topic>Human mycoses</topic><topic>Human viral diseases</topic><topic>Humans</topic><topic>Infectious diseases</topic><topic>Medical sciences</topic><topic>Meningitis, Cryptococcal - diagnosis</topic><topic>Meningitis, Cryptococcal - drug therapy</topic><topic>Meningitis, Cryptococcal - mortality</topic><topic>Meningitis, Cryptococcal - pathology</topic><topic>Miscellaneous mycoses</topic><topic>Mycoses</topic><topic>Prognosis</topic><topic>Survival Analysis</topic><topic>Thailand</topic><topic>Treatment Outcome</topic><topic>United States</topic><topic>Viral diseases</topic><topic>Viral diseases of the lymphoid tissue and the blood. Aids</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Anekthananon, T</creatorcontrib><creatorcontrib>Manosuthi, W</creatorcontrib><creatorcontrib>Chetchotisakd, P</creatorcontrib><creatorcontrib>Kiertiburanakul, S</creatorcontrib><creatorcontrib>Supparatpinyo, K</creatorcontrib><creatorcontrib>Ratanasuwan, W</creatorcontrib><creatorcontrib>Pappas, P G</creatorcontrib><creatorcontrib>Filler, S G</creatorcontrib><creatorcontrib>Kopetskie, H A</creatorcontrib><creatorcontrib>Nolen, T L</creatorcontrib><creatorcontrib>Kendrick, A S</creatorcontrib><creatorcontrib>Larsen, R A</creatorcontrib><creatorcontrib>BAMSG 3-01 Study Team</creatorcontrib><creatorcontrib>The Bamsg 3-01 Study Team</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of STD &amp; AIDS</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Anekthananon, T</au><au>Manosuthi, W</au><au>Chetchotisakd, P</au><au>Kiertiburanakul, S</au><au>Supparatpinyo, K</au><au>Ratanasuwan, W</au><au>Pappas, P G</au><au>Filler, S G</au><au>Kopetskie, H A</au><au>Nolen, T L</au><au>Kendrick, A S</au><au>Larsen, R A</au><aucorp>BAMSG 3-01 Study Team</aucorp><aucorp>The Bamsg 3-01 Study Team</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Predictors of poor clinical outcome of cryptococcal meningitis in HIV-infected patients</atitle><jtitle>International journal of STD &amp; AIDS</jtitle><addtitle>Int J STD AIDS</addtitle><date>2011-11-01</date><risdate>2011</risdate><volume>22</volume><issue>11</issue><spage>665</spage><epage>670</epage><pages>665-670</pages><issn>0956-4624</issn><eissn>1758-1052</eissn><abstract>The aim of this study was to identify baseline prognostic factors for poor clinical outcome of HIV-associated cryptococcal meningitis. We conducted a trial in Thailand and the USA comparing low- and high-dose concomitant use of amphotericin B and fluconazole for HIV-associated cryptococcal meningitis to amphotericin B followed by fluconazole. Subjects who were either alive and cerebrospinal fluid (CSF) culture-positive or dead were considered to have a poor outcome. At day 14, baseline characteristics associated with poor outcome included: low weight, high CSF cryptococcal antigen (CrAg) titre and low CSF white blood cell (WBC) count. At day 70, the associated baseline characteristics included: CSF CrAg titre &gt;1:1024 and low Karnofsky performance status. Overall, consistent with published findings, low weight, high CSF CrAg titre and low CSF WBC counts at baseline were predictors for poor clinical outcome. In addition, we found that low Karnofsky performance status was predictive of poor outcome. Prompt management with appropriate antifungal therapy for this particular group of patients may improve the outcomes.</abstract><cop>London, England</cop><pub>SAGE Publications</pub><pmid>22096053</pmid><doi>10.1258/ijsa.2011.010538</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0956-4624
ispartof International journal of STD & AIDS, 2011-11, Vol.22 (11), p.665-670
issn 0956-4624
1758-1052
language eng
recordid cdi_proquest_miscellaneous_912917549
source Sage Journals Online
subjects AIDS/HIV
Amphotericin B - administration & dosage
Antifungal Agents - administration & dosage
Biological and medical sciences
Cerebrospinal Fluid - microbiology
Cryptococcus
Fluconazole - administration & dosage
General aspects
HIV Infections - complications
Human immunodeficiency virus
Human mycoses
Human viral diseases
Humans
Infectious diseases
Medical sciences
Meningitis, Cryptococcal - diagnosis
Meningitis, Cryptococcal - drug therapy
Meningitis, Cryptococcal - mortality
Meningitis, Cryptococcal - pathology
Miscellaneous mycoses
Mycoses
Prognosis
Survival Analysis
Thailand
Treatment Outcome
United States
Viral diseases
Viral diseases of the lymphoid tissue and the blood. Aids
title Predictors of poor clinical outcome of cryptococcal meningitis in HIV-infected patients
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T19%3A32%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Predictors%20of%20poor%20clinical%20outcome%20of%20cryptococcal%20meningitis%20in%20HIV-infected%20patients&rft.jtitle=International%20journal%20of%20STD%20&%20AIDS&rft.au=Anekthananon,%20T&rft.aucorp=BAMSG%203-01%20Study%20Team&rft.date=2011-11-01&rft.volume=22&rft.issue=11&rft.spage=665&rft.epage=670&rft.pages=665-670&rft.issn=0956-4624&rft.eissn=1758-1052&rft_id=info:doi/10.1258/ijsa.2011.010538&rft_dat=%3Cproquest_cross%3E911162522%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c398t-a93358962a190cc2fa1208c31b6ef700af7974742ca735c01a57a8f0049aecf73%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=911162522&rft_id=info:pmid/22096053&rft_sage_id=10.1258_ijsa.2011.010538&rfr_iscdi=true